Sartaj Sanghera
Added Benefit With Higher GLP-1 RA Doses Higher doses of GLP-1 RAs have been studied for added glycemic and weight benefits in the treatment of T2D
And critically, they wanted to claim the product "wasn't tested on animals," which you can't do if you've run even one mouse trial
This guide examines theoretical cagrilintide dosage protocols when combined with tirzepatide, potential synergies and risks, conservative vs aggressive dosing strategies, comparing this combination to proven alternatives (CagriSema, tirzepatide monotherapy), who might consider this experimental approach, and safer evidence-based options that deliver comparable results
10.7759/cureus.9319 75 MarusichJ
In this episode, Scott dives into what really happens after the scale hits your number, how to maintain results, and why mindset matters more than ever